With the solution for efficient sharing of images, pathologists will be able to easily consult with other pathologists throughout the country or to ask for second opinions. The solution also makes a patient’s previous images easily available, regardless of where the study was carried out. In addition, the solution makes information readily available for panel discussions and supports their execution. All in all, the nationwide telepathology solution could greatly improve cancer care in the Netherlands.
The telepathology project was initiated by the Dutch Society of Pathologists (NVVP) and the nationwide network, Stichting PALGA. The project will be implemented by Sectra, together with the subcontractors Deutsche Telecom Healthcare Solutions and RAM IT. The Pathology Image Exchange solution is based upon a SaaS (Software as a Service) model. Pathology labs which choose to participate will be connected in the coming years.
“Implementing a pathology solution on this scale requires integration between several different IT solutions throughout the 50 labs. Sectra’s philosophy and proven track record of implementing standard-based integration is a core strength for us, which makes me extra proud to be part of this unique project,” says Dr. Torbjörn Kronander, President and CEO of Sectra.
Sectra’s digital pathology solution
Sectra provides a complete solution for primary diagnostics in pathology, including archiving and an advanced review workstation. The solution allows pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case, thereby improving cancer care. Sectra’s high-end review workstation provides pathologists with the right environment and tools to perform their work in a digital system and to reduce the pain-points associated with time-consuming and labor-intensive manual workflow. Sectra’s digital pathology solution also allows seamless sharing of digital slides and patient data in multi-hospital environments, enhancing the workflows around consultations, frozen sections and second opinions. In the US, digital pathology for primary diagnostics is still pending FDA approval. Read more about Sectra's digital pathology solution.
Source: press release Cision